WHO ICTRP trial
Safety evaluation of Uniform Particle NovaSil in Children (Phase I study)
PACTR201311000711179 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR201311000711179 |
|---|---|
| Public title | Safety evaluation of Uniform Particle NovaSil in Children (Phase I study) |
| Scientific title | Enterosorbent Intervention Therapies for Populations at risk of Aflatoxin-Related Diseases: Safety evaluation of Unifrom Particle NovaSil in Children (Phase I) |
| Primary sponsor | Noguchi Memorial Institute for Medical Research |
| Secondary sponsors | Texas A&M University |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Ghana;Ghana;Ghana;Ghana;Ghana;Ghana |
| Conditions | Injury, Occupational Diseases, Poisoning Paediatrics Aflatoxin exposure;Injury, Occupational Diseases, Poisoning;Paediatrics;Aflatoxin exposure |
| Interventions | Unifrom Particle Size NovaSil (UPSN) ;Unifrom Particle Size NovaSil (UPSN) ;Placebo |
| Registration date | Nov 22, 2013 |
| Target size | 75 |
| Secondary IDs | not applicable |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: